PerTe: efficacy and safety of pertuzumab in “real life setting” for the neoadjuvant treatment of HER2-positive breast cancer patientsD. Cianniello, A. Prudente,R. Caputo,M. Piezzo, M. Riemma, B. Savastano,S. Cocco, M. Licenziato, B. De Stefano, G. Di Gioia, G. Fusco, G. Buonfanti, A. Gravina, G. Landi,F. Di Rella, C. Pacilio,F. Nuzzo,G. Iodice,M. De Laurentiis,S. Del PreteAnnals of Oncology（2017）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
